Last month, Rabble announced that Vine, or something like it, is coming back. Funded with an investment by Jack Dorsey—who ...
Australian drug developer Biotron may have found a potential cure for Hepatitis C, after all patients who completed a trial of its lead antiviral drug emerged with undetectable levels of the virus.